CA3098006A1 — Solid dosage form having excellent stability
Assigned to Shionogi and Co Ltd · Expires 2019-10-31 · 7y expired
What this patent protects
Provided is a solid formulation containing a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, a stabilizer, a sugar alcohol and/or a saccharide, a water-soluble polymer, and an inorganic material, and the solid formulation exhibits a good stabili…
USPTO Abstract
Provided is a solid formulation containing a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, a stabilizer, a sugar alcohol and/or a saccharide, a water-soluble polymer, and an inorganic material, and the solid formulation exhibits a good stability, water suspendability, and flowability.
Drugs covered by this patent
- Xofluza (BALOXAVIR MARBOXIL) · Roche
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.